Pinto NR - Search Results

1

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL. Pinto NR, et al. J Clin Oncol. 2015 Sep 20;33(27):3008-17. doi: 10.1200/JCO.2014.59.4648. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304901 Free PMC article. Review.

2

Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.

Henderson TO, Bhatia S, Pinto N, London WB, McGrady P, Crotty C, Sun CL, Cohn SL. Henderson TO, et al. J Clin Oncol. 2011 Jan 1;29(1):76-82. doi: 10.1200/JCO.2010.29.6103. Epub 2010 Nov 22. J Clin Oncol. 2011. PMID: 21098321 Free PMC article.

3

Using germline genomics to individualize pediatric cancer treatments.

Pinto N, Cohn SL, Dolan ME. Pinto N, et al. Clin Cancer Res. 2012 May 15;18(10):2791-800. doi: 10.1158/1078-0432.CCR-11-1938. Clin Cancer Res. 2012. PMID: 22589487 Free PMC article. Review.

4

Trans-population analysis of genetic mechanisms of ethnic disparities in neuroblastoma survival.

Gamazon ER, Pinto N, Konkashbaev A, Im HK, Diskin SJ, London WB, Maris JM, Dolan ME, Cox NJ, Cohn SL. Gamazon ER, et al. J Natl Cancer Inst. 2013 Feb 20;105(4):302-9. doi: 10.1093/jnci/djs503. Epub 2012 Dec 14. J Natl Cancer Inst. 2013. PMID: 23243203 Free PMC article.

5

Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.

Pinto N, Cipkala DA, Ladd PE, Pu Y, Cohn SL. Pinto N, et al. Pediatr Blood Cancer. 2014 Jun;61(6):1104-6. doi: 10.1002/pbc.24889. Epub 2013 Nov 30. Pediatr Blood Cancer. 2014. PMID: 24293072

6

Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.

Pinto N, Gamazon ER, Antao N, Myers J, Stark AL, Konkashbaev A, Im HK, Diskin SJ, London WB, Ludeman SM, Maris JM, Cox NJ, Cohn SL, Dolan ME. Pinto N, et al. Clin Pharmacol Ther. 2014 Jun;95(6):644-52. doi: 10.1038/clpt.2014.37. Epub 2014 Feb 18. Clin Pharmacol Ther. 2014. PMID: 24549002 Free PMC article.

7

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Applebaum MA, Henderson TO, Lee SM, Pinto N, Volchenboum SL, Cohn SL. Applebaum MA, et al. Pediatr Blood Cancer. 2015 Jan;62(1):128-33. doi: 10.1002/pbc.25249. Epub 2014 Sep 23. Pediatr Blood Cancer. 2015. PMID: 25251613 Free PMC article.

8

Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.

Darlington WS, Pinto N, Hecktman HM, Cohn SL, LaBelle JL. Darlington WS, et al. Pediatr Blood Cancer. 2015 Dec;62(12):2232-4. doi: 10.1002/pbc.25650. Epub 2015 Jul 14. Pediatr Blood Cancer. 2015. PMID: 26174546 Clinical Trial.

9

Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.

Pinto N, Mayfield JR, Raca G, Applebaum MA, Chlenski A, Sukhanova M, Bagatell R, Irwin MS, Little A, Rawwas J, Gosiengfiao Y, Delattre O, Janoueix-Lerosey I, Lapouble E, Schleiermacher G, Cohn SL. Pinto N, et al. Pediatr Blood Cancer. 2016 Jun;63(6):1019-23. doi: 10.1002/pbc.25934. Epub 2016 Feb 10. Pediatr Blood Cancer. 2016. PMID: 26864375 Free PMC article.

10

Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.

Sokol E, Huang E, Pytel P, Cohn SL, Pinto N. Sokol E, et al. Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26226. Epub 2016 Sep 24. Pediatr Blood Cancer. 2017. PMID: 27663277 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page